Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art.

about

Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis

P2860

Q58765170-579E23BF-38B7-4111-89B0-65E5D8A76D15

P2860

Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art.

Item

http://www.wikidata.org/entity/Q49633716

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Drug-eluting beads transarteri ...... oma: Current state of the art.

@en

Drug-eluting beads transarteri ...... oma: Current state of the art.

@nl

type

Item

label

Drug-eluting beads transarteri ...... oma: Current state of the art.

@en

Drug-eluting beads transarteri ...... oma: Current state of the art.

@nl

prefLabel

Drug-eluting beads transarteri ...... oma: Current state of the art.

@en

Drug-eluting beads transarteri ...... oma: Current state of the art.

@nl

P1476

Drug-eluting beads transarteri ...... oma: Current state of the art.

@en

P2093

Antonio Facciorusso

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 4.0 License

P2860

Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients

Are hematopoietic stem cells involved in hepatocarcinogenesis?

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Does drug-eluting bead transcatheter arterial chemoembolization improve the management of patients with hepatocellular carcinoma? A meta-analysis

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.

Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

P304

161-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3748/WJG.V24.I2.161

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29375202

http://www.w3.org/2001/XMLSchema#string

P921

hepatocellular carcinoma

liver neoplasm

liver cancer

pharmaceutical preparation

P932

5768935

http://www.w3.org/2001/XMLSchema#string

Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art.

about

P2860

P2860

Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932